Yu LY, Zhang XF. Beyond efficacy: Insights from the norursodeoxycholic acid phase III trial in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(8): 117543 [DOI: 10.4254/wjh.117543]
Please LOGIN to submit a new comment.